Invivyd, Inc. (IVVD)
2025-06-30 | 2025-03-31 | 2024-09-30 | ||
|---|---|---|---|---|
| Total revenue | 11,786 | 11,304 | 9,300 | |
| Selling, general and administrative | 16,588 | 16,751 | 12,955 | |
| Research and development | 9,573 | 10,641 | 57,850 | |
| Cost of product revenue | 685 | 834 | 806 | |
| Total operating costs and expenses | 26,846 | 28,226 | 71,611 | |
| Loss from operations | -15,060 | -16,922 | -62,311 | |
| Other income, net | 400 | 633 | 1,572 | |
| Total other income, net | 400 | 633 | 1,572 | |
| Net loss | -14,660 | -16,289 | -60,739 | |
| Unrealized (loss) gain, net of tax | -26 | -8 | -6 | |
| Comprehensive loss | -14,686 | -16,297 | -60,745 | |
| Earnings per share, basic | -0.12 | -0.14 | -0.51 | |
| Earnings per share, diluted, total | -0.12 | -0.14 | -0.51 | |
| Weighted average number of shares outstanding, diluted | 120,016,132 | 119,883,479 | 119,495,284 | |
| Weighted-average common shares outstanding, basic | 120,016,132 | 119,883,479 | 119,495,284 | |